Thyroid Disorders and Fertility: How Hypothyroidism and Hashimoto’s Affect Conception
How Thyroid Dysfunction Can Influence Ovulation, Implantation, and Early Pregnancy
Difficulty getting pregnant is not always caused by a problem within the reproductive organs themselves. Thyroid function influences ovulation, menstrual cycle regulation, progesterone production, endometrial receptivity, implantation, and the early stages of pregnancy.
Overt hypothyroidism is a well-established cause of reproductive dysfunction. Hashimoto’s thyroiditis is more complicated. Thyroid autoimmunity can be present before thyroid hormone production becomes clearly abnormal, but its reproductive significance varies and should not be assumed from antibody positivity alone. Overt hypothyroidism, subclinical hypothyroidism, and thyroid autoimmunity are related conditions, but they should not be treated as interchangeable diagnoses (1).
TSH is an important part of thyroid assessment, but a single TSH value should never be interpreted apart from the clinical history. Previous thyroid abnormalities, Hashimoto’s thyroiditis, menstrual changes, recurrent pregnancy loss, persistent thyroid symptoms, medication use, and changes in thyroid function over time can all affect how laboratory results are interpreted (2).
Thyroid hormones influence ovarian function, metabolic activity, reproductive hormone signaling, and the physiologic adaptations required to establish and maintain an early pregnancy. When clinically meaningful thyroid dysfunction is present, reproductive effects can include:
Irregular or absent ovulation
Changes in menstrual cycle timing
Reduced or inconsistent progesterone production and luteal-phase function
Changes in endometrial receptivity
Difficulty conceiving
Greater risk of pregnancy complications when overt thyroid disease is untreated
Infertility is often multifactorial, and an abnormal thyroid result should not automatically be treated as the explanation for why conception is difficult. Ovarian reserve, ovulatory function, reproductive hormones, metabolic health, uterine and tubal factors, age, medications, and male-factor fertility may also be contributing.
→ Women’s Hormone & Fertility Support
How Can Thyroid Disorders Affect Fertility?
Thyroid disorders can affect fertility by disrupting ovulation, menstrual cycle regulation, progesterone production, endometrial receptivity, and early pregnancy physiology. These effects are well established in overt hypothyroidism. The significance of subclinical hypothyroidism and thyroid autoimmunity is less consistent and depends on the degree of thyroid dysfunction, antibody status, reproductive history, and the broader fertility evaluation (1,2).
How Thyroid Hormones Affect Ovulation, Implantation, and Fertility
Thyroid hormones influence far more than metabolic rate. They act throughout the reproductive system, affecting ovarian function, menstrual cycle regulation, endometrial development, progesterone production, and the cellular energy demands of conception and early pregnancy (1).
When thyroid hormone production is significantly impaired, several parts of reproductive physiology can be disrupted at once. Ovulation may become delayed or inconsistent, menstrual cycles may lengthen or become less predictable, progesterone production may decline, and the endometrium may be less well prepared for implantation (1,3).
Some women continue to menstruate regularly despite changes in ovulatory timing or post-ovulatory hormone production. A monthly period does not necessarily tell us whether ovulation is occurring consistently or whether the luteal phase is producing adequate hormonal support.
Thyroid Hormones and the Metabolic Demands of Reproduction
Follicle development, ovulation, implantation, placental development, and early pregnancy require considerable cellular energy. These processes depend on mitochondrial energy production, oxygen utilization, nutrient availability, and coordinated hormone signaling. Thyroid hormones help regulate metabolic activity and mitochondrial function throughout the body, including within ovarian and reproductive tissues (1).
Clinically significant hypothyroidism can disrupt several parts of reproductive physiology at the same time:
Hypothalamic and pituitary signaling
Ovarian responsiveness to FSH and LH
Follicle development and ovulation
Progesterone production after ovulation
Endometrial preparation for implantation
Thyroid hormone receptors and TSH receptors have also been identified in reproductive tissues, including the ovary and endometrium, providing a biologically plausible pathway for direct interaction between thyroid signaling and reproductive function (3).
Mild and Subclinical Thyroid Dysfunction
Overt hypothyroidism has well-established reproductive consequences. Subclinical hypothyroidism is less straightforward.
Subclinical hypothyroidism generally refers to an elevated TSH with free thyroxine remaining within the laboratory reference range. A mildly elevated TSH does not automatically mean that thyroid dysfunction is responsible for infertility, implantation failure, or miscarriage (2).
A TSH between 2.5 and 4.0 mIU/L should not automatically be interpreted as a fertility disorder. Current reproductive-medicine guidance does not find sufficient evidence that this TSH range itself causes infertility or increases miscarriage risk (2).
Interpretation depends on the degree of TSH elevation, the laboratory reference range, previous thyroid history, symptoms, thyroid antibody status, pregnancy status, medication use, and the broader fertility evaluation.
Thyroid physiology also involves hormone conversion, transport, receptor activity, and cellular response (1,3). These mechanisms are biologically important, but they should not be used to assume that normal thyroid bloodwork is masking clinically significant hypothyroidism simply because conception has been difficult.
Mild and Subclinical Thyroid Dysfunction
Overt hypothyroidism has well-established reproductive consequences. Subclinical hypothyroidism is less straightforward.
Subclinical hypothyroidism generally refers to an elevated TSH with free thyroxine remaining within the laboratory reference range. A mildly elevated TSH does not automatically mean that thyroid dysfunction is responsible for infertility, implantation failure, or miscarriage (2).
A TSH between 2.5 and 4.0 mIU/L should not automatically be interpreted as a fertility disorder. Current reproductive-medicine guidance does not find sufficient evidence that this TSH range itself causes infertility or increases miscarriage risk (2).
Interpretation depends on the degree of TSH elevation, the laboratory reference range, previous thyroid history, symptoms, thyroid antibody status, pregnancy status, medication use, and the broader fertility evaluation.
Thyroid physiology also involves hormone conversion, transport, receptor activity, and cellular response (1,3). These mechanisms are biologically important, but they should not be used to assume that normal thyroid bloodwork is masking clinically significant hypothyroidism simply because conception has been difficult.
How Hypothyroidism Affects Ovulation and Menstrual Cycles
Ovulation depends on coordinated signaling between the hypothalamus, pituitary gland, and ovaries. This hypothalamic–pituitary–ovarian axis regulates follicle development, ovulation, progesterone production, and menstrual cycle timing (1).
Hypothyroidism can disrupt this signaling without stopping menstruation altogether. Cycles may lengthen, ovulation may become delayed or less predictable, and post-ovulatory hormone production can become less reliable.
Hypothyroidism and the Hypothalamic–Pituitary–Ovarian Axis
The hypothalamus releases gonadotropin-releasing hormone (GnRH), which directs the pituitary gland to release follicle-stimulating hormone (FSH) and luteinizing hormone (LH). These hormones drive follicular development, ovulation, and subsequent corpus luteum function.
Reduced thyroid hormone activity can alter hypothalamic and pituitary signaling while also affecting ovarian responsiveness to LH and FSH (1).
Depending on the severity of hypothyroidism, reproductive changes may include:
Delayed or inconsistent ovulation
Irregular or longer menstrual cycles
Anovulatory cycles
Changes in luteal-phase function
Reduced fertility
Regular menstrual bleeding does not necessarily confirm that ovulation is occurring consistently. A woman may continue having monthly periods while ovulatory timing, follicular development, or post-ovulatory hormone production has become less predictable.
Hypothyroidism, TRH, and Prolactin
Prolactin deserves particular attention when hypothyroidism and ovulatory dysfunction occur together.
As thyroid hormone production falls, hypothalamic thyrotropin-releasing hormone (TRH) can increase in an effort to stimulate the thyroid axis. TRH stimulates TSH secretion from the pituitary, but it can also increase prolactin release.
When prolactin becomes elevated, it can suppress GnRH pulsatility and disrupt the LH and FSH signaling required for normal follicular development and ovulation. Depending on the degree of elevation, this can contribute to delayed ovulation, irregular cycles, anovulation, or infertility (1).
For this reason, prolactin can be an important part of the evaluation when hypothyroidism occurs alongside menstrual irregularity or suspected ovulatory dysfunction.
Progesterone and Luteal-Phase Function
Conception depends not only on releasing an egg, but also on what happens after ovulation.
The corpus luteum produces progesterone following ovulation, helping transform and maintain the endometrium for implantation. When ovulation is inconsistent or corpus luteum function is impaired, progesterone production and luteal-phase function can also be affected (4).
This can present as:
Short or inconsistent luteal phases
Premenstrual spotting
Lower progesterone production
Inadequate progesterone support of the endometrium
Difficulty conceiving despite apparently regular cycles
None of these findings is specific to thyroid disease. But when they occur alongside hypothyroidism, Hashimoto’s thyroiditis, or a change in menstrual patterns, they are a reason to look more closely at ovulatory and post-ovulatory hormone function rather than assuming that regular bleeding means the cycle is functioning normally.
Hashimoto’s Thyroiditis, Thyroid Antibodies, and Fertility
With Hashimoto’s thyroiditis, thyroid hormone levels do not tell the whole story. Hashimoto’s is an autoimmune thyroid disease, most commonly associated with thyroid peroxidase (TPO) antibodies and thyroglobulin antibodies.
Thyroid antibodies can appear before overt hypothyroidism develops. Some women remain euthyroid for years despite positive antibodies, while others gradually develop changes in thyroid function. Antibody positivity does not prove that Hashimoto’s is causing infertility, but it does identify an autoimmune thyroid pattern that should be interpreted in the context of the broader reproductive picture (5).
What Thyroid Antibodies Actually Tell Us
A positive TPO or thyroglobulin antibody confirms thyroid autoimmunity, but it does not tell us whether that autoimmunity is impairing fertility.
Positive antibodies do not automatically mean:
Ovulation is impaired
Implantation will fail
Miscarriage will occur
IVF will be unsuccessful
Thyroid hormone replacement is indicated
Lowering antibody levels will improve fertility
Studies have reported associations between thyroid autoimmunity and poorer reproductive outcomes in some populations, particularly recurrent pregnancy loss, but the findings are not consistent across all studies or fertility settings (5,6).
The antibodies themselves may not be the direct cause. They may identify women with evolving thyroid dysfunction, broader autoimmune susceptibility, or other factors that overlap with fertility problems (5).
For that reason, thyroid antibodies are best interpreted as part of the broader clinical pattern rather than as a standalone explanation for infertility.
→ Immune Health & Autoimmune Support
Hashimoto’s, Implantation, and Early Pregnancy Loss
Implantation depends on tightly regulated immune signaling. The maternal immune system has to allow implantation and placental development while still maintaining normal immune defense.
Because Hashimoto’s is autoimmune, researchers have looked closely at thyroid antibodies in women with infertility and recurrent pregnancy loss.
Some studies have found higher miscarriage rates in women with thyroid autoimmunity, while others have found weaker associations or no clear difference once age, thyroid function, and other fertility factors are taken into account (5–7).
That means thyroid antibodies should not be treated as a direct explanation for miscarriage or implantation failure.
They become more relevant when recurrent pregnancy loss occurs alongside Hashimoto’s thyroiditis, changing thyroid function, or another autoimmune condition. Even then, the antibodies are only one part of the picture.
When Thyroid Antibody Testing Adds Useful Information
Thyroid antibody testing is not necessary for every woman trying to conceive. It becomes more useful when the history raises concern for Hashimoto’s thyroiditis or changing thyroid function (2).
Testing is more relevant with:
Known or suspected Hashimoto’s thyroiditis
Previously abnormal or fluctuating thyroid tests
Recurrent pregnancy loss
Persistent symptoms consistent with thyroid dysfunction
Other autoimmune disease
A strong family history of autoimmune thyroid disease
Changing thyroid requirements before or during pregnancy
The antibody result still needs to be interpreted alongside TSH, thyroid hormone levels, previous laboratory trends, symptoms, medication use, ovulatory function, and pregnancy history.
A positive antibody test can confirm thyroid autoimmunity. It cannot tell us by itself whether the thyroid is affecting fertility or what treatment is needed.
→ Advanced Functional Lab Testing
Can You Have Thyroid-Related Infertility With Normal Thyroid Labs?
Yes, but the result needs context.
A normal TSH makes overt hypothyroidism less likely. It does not erase a history of Hashimoto’s thyroiditis, previous thyroid abnormalities, recurrent pregnancy loss, menstrual changes, or thyroid function that has shifted significantly over time (2,5).
Sometimes the thyroid still deserves a closer look. In other cases, the main fertility problem lies elsewhere.
What TSH Can—and Cannot—Tell Us About Fertility
TSH reflects pituitary signaling to the thyroid and remains a central part of thyroid assessment (2).
What it does not tell us by itself is whether thyroid autoimmunity is present, whether thyroid function has been changing over time, how medication is influencing the laboratory picture, or whether another endocrine problem is contributing to infertility.
A more comprehensive assessment should include:
Free or total T4
Thyroid antibodies when indicated
Previous TSH and thyroid hormone trends
Current thyroid medication and dose
Menstrual and ovulatory patterns
Pregnancy and miscarriage history
Other reproductive and endocrine findings
Thyroid hormone also has to be transported, converted, and recognized by receptors at the cellular level (1,3). Those processes are part of normal thyroid physiology, but they should not be used as a catch-all explanation for infertility when standard thyroid testing is normal.
When Thyroid Testing Should Go Beyond TSH
A closer look at thyroid function is more reasonable when infertility occurs alongside:
Known Hashimoto’s thyroiditis
Positive thyroid antibodies
Previously abnormal or fluctuating TSH
Thyroid medication use
Irregular or changing menstrual cycles
Recurrent pregnancy loss
Persistent symptoms consistent with thyroid dysfunction
Other autoimmune or endocrine conditions
The point is not to keep ordering thyroid tests until something turns abnormal. The question is whether thyroid dysfunction is actually contributing to the fertility problem (2,5).
That answer has to be considered alongside ovulation, reproductive hormones, ovarian reserve, age, uterine and tubal factors, metabolic health, medications, nutrient status, and male-factor fertility.
Why Correcting Thyroid Dysfunction May Require More Than Medication
When thyroid hormone replacement is needed, treatment is not limited to one formulation. Options may include synthetic T4, combination T4/T3 therapy, or desiccated thyroid preparations, depending on the clinical picture, laboratory findings, response to treatment, and prescribing context.
Replacing thyroid hormone does not necessarily address why thyroid function became impaired in the first place.
Thyroid hormone synthesis and metabolism depend on adequate nutrient availability, normal conversion pathways, pituitary signaling, and healthy thyroid tissue. With Hashimoto’s thyroiditis, autoimmune activity adds another factor that hormone replacement alone does not resolve.
For some women, improving thyroid function also requires correcting deficiencies, addressing metabolic or gastrointestinal problems, reducing inflammatory burden, and using targeted herbal or nutraceutical support. Thyroid medication may remain part of treatment when needed, but it is one tool within a larger thyroid and fertility strategy.
What a Comprehensive Thyroid and Fertility Evaluation Can Include
A useful thyroid evaluation goes beyond whether TSH falls inside a reference range.
Additional assessment may include:
Iron status and ferritin
Selenium and zinc status
Iodine intake and exposure
Vitamin D status
Blood sugar regulation and insulin resistance
Gastrointestinal dysfunction or impaired nutrient absorption
Hashimoto’s thyroiditis and other autoimmune disease
Medications that affect thyroid function or thyroid hormone absorption
Thyroid hormone conversion
Reproductive hormone abnormalities
These findings need to be interpreted individually. Iodine is essential for thyroid hormone synthesis, but excess intake can worsen thyroid dysfunction in susceptible patients. Iron is required for normal thyroid peroxidase activity, while selenium-dependent enzymes are involved in thyroid hormone metabolism and antioxidant protection within the thyroid (8).
Gastrointestinal dysfunction can also matter when it affects nutrient absorption or the absorption of prescribed thyroid hormone.
The purpose of a broader evaluation is not to order more tests simply because they are available. It is to identify the factors that are actually interfering with thyroid function and determine whether any of them are also relevant to fertility.
Hashimoto’s Requires More Than TSH Monitoring
Hashimoto’s thyroiditis should be approached as both a thyroid disorder and an autoimmune condition.
Normalizing TSH can correct hypothyroidism, but it does not eliminate thyroid autoimmunity. Persistent antibody positivity does not automatically explain infertility, yet it can remain clinically relevant when accompanied by nutrient deficiencies, other autoimmune disease, inflammatory activity, or changing thyroid function (5).
Treatment depends on what is actually contributing. That may mean correcting nutrient deficiencies, addressing gastrointestinal or metabolic problems, using targeted herbal or nutraceutical support, and replacing thyroid hormone when needed.
The point is not to keep ordering thyroid markers until something becomes abnormal. Testing should clarify whether thyroid dysfunction is actually contributing to the fertility problem (2,5).
When Fertility Problems Continue After Thyroid Function Improves
If thyroid function improves but conception remains difficult, the evaluation should move beyond the thyroid rather than continuing to intensify thyroid treatment without a clear reason.
Other contributors may include:
Inconsistent ovulation
Progesterone or luteal-phase dysfunction
Elevated prolactin
PCOS
Insulin resistance
Endometriosis
Diminished ovarian reserve
Uterine or tubal factors
Nutrient deficiencies
Other endocrine or autoimmune conditions
Male-factor infertility
A well-managed thyroid removes one potential barrier to conception. It does not rule out the others.
The next step is to determine which reproductive, endocrine, metabolic, structural, or immune factors are still interfering with fertility and address those directly.
Thyroid Dysfunction, IVF, and Assisted Reproductive Outcomes
Thyroid function deserves closer attention during IVF because ovarian stimulation and early pregnancy can change thyroid hormone requirements, particularly in women with pre-existing hypothyroidism or Hashimoto’s thyroiditis (4,9). The degree to which thyroid disease affects treatment outcomes, however, depends heavily on what type of thyroid dysfunction is actually present.
Overt hypothyroidism deserves treatment and close management before conception and during pregnancy. The evidence is much less clear for mild TSH elevations and for thyroid antibodies in women who otherwise have normal thyroid hormone levels.
Overt Hypothyroidism and IVF
Untreated or inadequately treated overt hypothyroidism can interfere with normal reproductive function and carries established risks for pregnancy (4,9). For women undergoing IVF, identifying clinically significant hypothyroidism before treatment is therefore important.
Thyroid function can also change during ovarian stimulation and early pregnancy as estrogen levels rise and thyroid hormone requirements shift (4,9). Women with established hypothyroidism or Hashimoto’s thyroiditis may need closer laboratory follow-up during this period, particularly once pregnancy is achieved.
The goal is adequate thyroid function—not simply pushing TSH below an arbitrary fertility threshold.
Subclinical Hypothyroidism During Fertility Treatment
Subclinical hypothyroidism is far less straightforward.
Older fertility protocols often treated relatively small TSH elevations aggressively, particularly values above 2.5 mIU/L. More recent evidence does not support assuming that a TSH between 2.5 and 4.0 mIU/L reduces IVF success or increases miscarriage risk (2).
Current reproductive-medicine guidance finds insufficient evidence that subclinical hypothyroidism causes infertility and has not shown improved clinical pregnancy or live-birth rates from routinely treating mild TSH elevations solely to improve fertility outcomes (2).
That does not make thyroid testing irrelevant. A woman with symptoms of hypothyroidism, known thyroid disease, irregular cycles, previous abnormal thyroid testing, Hashimoto’s thyroiditis, or other risk factors still warrants appropriate thyroid evaluation.
A mildly elevated TSH therefore should not automatically be blamed for a failed IVF cycle or treated as the explanation for infertility.
Hashimoto’s and Thyroid Antibodies in IVF: What the Evidence Shows
Thyroid autoimmunity has been studied extensively in women undergoing IVF, but the results are not consistent enough to support a simple conclusion.
Some studies have reported higher miscarriage rates or lower implantation rates in women with TPO antibodies. Others have found no meaningful difference in pregnancy or live-birth rates between euthyroid women with and without thyroid antibodies (5,7).
Several factors make these studies difficult to compare. Women differ in age, ovarian reserve, TSH levels, degree of thyroid autoimmunity, infertility diagnosis, IVF protocol, embryo quality, and whether thyroid treatment was already being used.
For a woman with Hashimoto’s, the antibody result is therefore one part of the case—not a prediction of whether IVF will succeed.
Thyroid autoimmunity deserves closer attention when it occurs alongside:
Changing or borderline thyroid function
Established hypothyroidism
Recurrent pregnancy loss
Other autoimmune disease
Symptoms consistent with thyroid dysfunction
Increasing thyroid hormone requirements
In these situations, the thyroid deserves careful management throughout fertility treatment and early pregnancy. Positive antibodies alone, however, should not be presented as proof of implantation failure or as the reason an IVF cycle was unsuccessful.
A Root-Cause Evaluation for Thyroid-Related Fertility Problems
When thyroid dysfunction is part of a fertility case, two questions need to be answered: how much the thyroid is contributing, and what else may be interfering with conception or pregnancy.
Restoring thyroid function will not resolve PCOS, insulin resistance, endometriosis, diminished ovarian reserve, hyperprolactinemia, uterine or tubal disease, nutrient deficiencies, or male-factor infertility. The reverse is also true: finding one of those problems does not make a clinically significant thyroid disorder irrelevant.
The evaluation should be guided by the history, symptoms, reproductive pattern, and laboratory findings rather than by a standard fertility panel applied to every patient.
Thyroid Function and Autoimmunity
Thyroid assessment may include TSH, circulating thyroid hormone levels, previous laboratory trends, treatment history, and thyroid antibodies when there is a clinical reason to test them.
With Hashimoto’s thyroiditis, thyroid hormone deficiency and thyroid autoimmunity need to be considered separately. They overlap, but they are not the same problem.
Trends also matter. Thyroid function and thyroid hormone requirements can change during fertility treatment and early pregnancy, making previous results and treatment response relevant to preconception planning (2,5,9).
Ovulation and Reproductive Hormones
A regular menstrual cycle does not necessarily confirm normal ovulation or adequate post-ovulatory hormone production.
Depending on the history, evaluation may include:
Ovulation timing and consistency
Progesterone production after ovulation
Prolactin
LH and FSH
Estradiol
Androgen patterns when PCOS is suspected
Ovarian reserve when appropriate
Timing matters with reproductive hormone testing. A progesterone value drawn at the wrong point in the cycle, for example, may be far less useful than a correctly timed result interpreted alongside ovulation and cycle history.
Hormone values are most useful when they answer a specific clinical question rather than being interpreted in isolation (1).
Metabolic and Nutrient Factors
Metabolic dysfunction can affect fertility independently of thyroid disease. Insulin resistance and blood sugar dysregulation can alter ovulatory function and reproductive hormone signaling, particularly in women with PCOS or other metabolic features.
Nutrient assessment is most useful when diet, symptoms, medical history, or previous laboratory findings suggest deficiency or increased need. Iron, selenium, zinc, iodine, vitamin D, folate, B12, and other nutrients can be relevant to thyroid physiology, reproductive function, or pregnancy preparation.
The point is not to test every nutrient. It is to identify deficiencies or metabolic abnormalities that are actually present and determine whether correcting them is likely to improve thyroid or reproductive function (8).
Other Causes of Infertility Still Need to Be Evaluated
A thyroid diagnosis should not become the endpoint of a fertility evaluation.
Persistent infertility may also involve:
Endometriosis
PCOS
Diminished ovarian reserve
Uterine abnormalities
Tubal disease
Recurrent pregnancy loss disorders
Other endocrine conditions
Autoimmune disease
Age-related fertility changes
Male-factor infertility
In some women, thyroid dysfunction is a major contributor. In others, it is one part of a more complicated case or an incidental finding that has little to do with why conception is difficult.
A root-cause evaluation should make the case more specific, not more complicated. The value is in identifying the factors that are actually interfering with fertility and addressing those directly.
When Thyroid Dysfunction Is Part of the Fertility Picture
Thyroid disease can be an important contributor to infertility, but it is rarely useful to interpret it in isolation.
Overt hypothyroidism, Hashimoto’s thyroiditis, thyroid antibodies, subclinical thyroid dysfunction, ovulatory changes, and recurrent pregnancy loss do not carry the same clinical meaning. The value of thyroid testing lies in understanding which findings are actually relevant to the fertility problem and which are not.
For some women, correcting thyroid dysfunction is a major part of restoring reproductive function. For others, the thyroid is only one contributor among several. The most useful approach is to identify what is actually interfering with conception—then treat those factors directly rather than continuing to focus on a single laboratory value or diagnosis.
If thyroid dysfunction, Hashimoto’s thyroiditis, recurrent pregnancy loss, irregular ovulation, or unexplained difficulty conceiving are part of your history, a comprehensive evaluation can help determine whether thyroid dysfunction is a meaningful contributor and what else needs to be addressed.
Frequently Asked Questions About Thyroid Disorders and Fertility
Can thyroid problems cause infertility?
Yes. Overt hypothyroidism can interfere with ovulation, menstrual cycle regulation, progesterone production, and early pregnancy physiology. Thyroid disease is therefore an important part of the fertility evaluation when laboratory abnormalities, Hashimoto’s thyroiditis, menstrual changes, or other thyroid findings are present.
Can hypothyroidism make it harder to get pregnant?
Yes. Significant hypothyroidism can disrupt ovulation, lengthen or alter menstrual cycles, raise prolactin, and affect progesterone production after ovulation. Treating established hypothyroidism can remove one important barrier to conception, although other causes of infertility may still need to be addressed.
Can Hashimoto’s thyroiditis affect fertility?
It can. Hashimoto’s can eventually lead to hypothyroidism, which has well-established effects on reproductive function. Thyroid antibodies have also been associated with miscarriage and other fertility outcomes in some studies, but antibody positivity alone does not prove that Hashimoto’s is causing infertility.
Can you have thyroid-related fertility problems with a normal TSH?
Yes, in some cases. A normal TSH makes overt hypothyroidism less likely, but it does not erase a history of Hashimoto’s thyroiditis, previously abnormal thyroid testing, changing thyroid function, recurrent pregnancy loss, or other relevant findings. Normal thyroid testing should also not be used to assume that every unexplained fertility problem is thyroid-related.
What TSH level is best for getting pregnant?
There is no single TSH level that guarantees fertility. A TSH below 2.5 mIU/L has often been treated as a universal preconception target, but current reproductive-medicine guidance does not support automatically labeling every TSH between 2.5 and 4.0 mIU/L as abnormal for fertility. Thyroid history, laboratory reference range, pregnancy status, symptoms, and other fertility findings all affect interpretation.
Can high TSH stop ovulation?
Yes, when the elevation reflects significant hypothyroidism. Hypothyroidism can alter hypothalamic and pituitary signaling, increase prolactin, and interfere with the LH and FSH patterns required for normal ovulation. A mildly elevated TSH does not automatically mean ovulation has stopped or become abnormal.
Can hypothyroidism cause low progesterone?
It can contribute indirectly. If hypothyroidism disrupts ovulation or corpus luteum function, progesterone production after ovulation may also be reduced or inconsistent. Low progesterone has many other possible causes, so it should be interpreted alongside ovulation timing, menstrual history, and other reproductive hormone findings.
Can thyroid problems cause miscarriage?
Untreated overt hypothyroidism is associated with a higher risk of pregnancy complications, including pregnancy loss. Thyroid autoimmunity has also been associated with miscarriage in some studies, but the evidence is less consistent when thyroid hormone levels are normal. A positive TPO or thyroglobulin antibody does not establish the cause of a miscarriage by itself.
Can Hashimoto’s cause miscarriage even if TSH is normal?
Possibly, but the relationship is not straightforward. Some studies have found higher pregnancy-loss rates in euthyroid women with thyroid autoimmunity, while others have not found the same degree of risk. A normal TSH does not make Hashimoto’s irrelevant, but positive thyroid antibodies should not be treated as proof that autoimmunity caused the miscarriage.
Should thyroid antibodies be tested when trying to conceive?
Not in every woman. Thyroid antibody testing becomes more useful with known or suspected Hashimoto’s thyroiditis, recurrent pregnancy loss, previous abnormal thyroid testing, other autoimmune disease, or a strong family history of autoimmune thyroid disease. The result should be interpreted with thyroid hormone levels and the fertility history rather than as a standalone marker.
Does thyroid medication improve fertility?
When hypothyroidism is present, correcting thyroid hormone deficiency can improve thyroid physiology and remove one potential obstacle to normal reproductive function. When thyroid hormone replacement is needed, different formulations may be considered based on the patient, laboratory findings, symptoms, and treatment response. Thyroid treatment does not correct unrelated fertility problems such as endometriosis, PCOS, diminished ovarian reserve, tubal disease, or male-factor infertility.
Can thyroid problems affect IVF success?
Overt hypothyroidism should be identified and treated before and during IVF. The evidence is much less convincing that mild TSH elevations or thyroid antibodies in otherwise euthyroid women consistently reduce implantation, clinical pregnancy, or live-birth rates. Thyroid status still deserves appropriate monitoring during ovarian stimulation and early pregnancy.
Do thyroid antibodies affect IVF outcomes?
The evidence is mixed. Some studies have reported higher miscarriage rates or lower implantation rates in women with thyroid autoimmunity, while others have found no significant difference in clinical pregnancy or live birth. Thyroid antibodies should therefore be considered as one part of the case rather than used to predict whether IVF will succeed.
Why am I still not getting pregnant after my thyroid levels improve?
Because thyroid dysfunction may have been only one part of the fertility problem. Persistent difficulty conceiving can still involve inconsistent ovulation, PCOS, endometriosis, elevated prolactin, diminished ovarian reserve, insulin resistance, uterine or tubal disease, nutrient deficiencies, other endocrine conditions, autoimmune disease, or male-factor infertility.
Improved thyroid function is important when hypothyroidism was present, but it does not rule out other causes of infertility.
Still Have Questions?
If the topics above reflect ongoing symptoms or unanswered concerns, a brief conversation can help clarify whether a root-cause approach is appropriate.
Resources
International Journal of Molecular Sciences- The Thyroid Hormone Axis and Female Reproduction
Fertility and Sterility / American Society for Reproductive Medicine- Subclinical Hypothyroidism in the Infertile Female Population: A Guideline
Journal of Reproductive Immunology- Thyroid Hormone Receptors and Reproduction
European Thyroid Journal- 2021 European Thyroid Association Guideline on Thyroid Disorders Prior to and During Assisted Reproduction
Seminars in Reproductive Medicine- A Review of Autoimmune Thyroid Diseases and Their Complex Interplay with Female Fertility
Journal of Reproductive Immunology- Recurrent Pregnancy Loss and Thyroid Autoimmunity: A Review of Mechanisms and Clinical Management
Reproductive Biology and Endocrinology- Thyroid Autoimmunity and IVF/ICSI Outcomes in Euthyroid Women: A Systematic Review and Meta-Analysis
Nutrients- Selenium, Iodine and Iron–Essential Trace Elements for Thyroid Hormone Synthesis and Metabolism
Thyroid / American Thyroid Association- American Thyroid Association 2026 Guidelines for Thyroid Disease in Preconception, Pregnancy, and Postpartum